NOBEL MEDICUS, cilt.10, sa.1, ss.47-52, 2014 (SCI-Expanded)
Objective: This study was planned to evaluate our approach to latent tuberculosis infection in patients who are given anti-tumornecrosis factor-alpha (TNF-alpha) therapy.